Yea sorry it's questionable to say that EBIX is low-balling when there is a market price 20% lower. And it's just absurd to say that EBIX is overvalued and will collapse and be bought by PN.
I agree re Robin being disciplined, of course, but just to clarify, Xchanging didn't get greedy, EBIX got outbid by CSC, which upped its initial offer and ultimately took over Xchanging.
This complaint applies to pretty much every government regulatory body. Politics, graft, self-interest infect public actions every bit as much as private actions, but at least there's the prospect of competition in the private sector. Not so with the government.
Perhaps some of the recent firming-up of EBIX share price has to do with weakening dollar outlook? I saw a headline re Indian rupee strengthening against dollar, and more importantly the weak jobs report means no June Fed rate hike and continued weakness means future rate hikes delayed. EBIX has in the past few years suffered millions of dollars of revenue from currency movements. Maybe now we'll finally be on the other side and benefit from them. Who knows...
...the FDA trying very very very hard to find a way to approve this?
Bending over backward to approve...
If there is any conceivable way to escape from under the analysis presented at the AdCom, they're looking for it.
If you think there's no possible evidence that can be mustered, then I don't think you're thinking properly. This isn't about weighing the evidence scientifically and finding it lacking. They could have done that already. This is clearly now about finding a hook or a purchase on which to rest a decision without looking bad. They're going to find something. A government bureaucracy, even a science-based one, is a government bureaucracy--a political animal--first.
I agree re Brexit. I wouldn't mind seeing Britain leave, just to show the world that consolidation of power doesn't have to be a one-way ticket and that the parade of horribles is exaggeration and fear-mongering. It's probably going to be okay.
I was thinking something similar earlier. Out of 30 stocks on my watch list, three are red, only EBIX substantially so.
Is the possibility of Brexit weighing on EBIX? I've seen articles talking about how Brexit would lead to a move from London to Singapore and New York of substantial insurance industry activity. Would undermine the promise of the PPL deal. May have some follow-on effects both good and bad for EBIX, but the first-order effect would be bad for Ebix's PPL deal...
Was this board ever not in the toilet?
Signal-to-noise ratio lowest I've ever seen...
Not entirely unentertaining tho
well, you can always sue, but SRPT almost certainly wouldn't get anywhere
Courts are VERY, VERY deferential to agency decision-making like this...
Aspirational goal of $350m rev run rate this time next year. Say they achieve $330m. That makes the numbers super easy. ~33m diluted shares outstanding according to press release. So nice round number of $10/share in revs. RR's laser focus on at least 35% margins means $3.50 annual EPS. P/E of 20 means $70 pps. Voila!
Share buyback, higher rev, higher P/E all sweeten the final value.